Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial. - Wikidata - wikimedia - TriplyDB

Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial.

Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial.

http://www.wikidata.org/entity/Q37725008

about

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia Corrigendum to "Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial".Kampo Medicines for Frailty in Locomotor Disease.Medicinal herbs in the treatment of neuropathic pain: a review.

P2860

Q28270819-A91E962F-FB5D-43B8-ACE5-D6A6EBE7BF55 Q36535037-98AAF73D-FA76-435B-841A-4006A1F44A47 Q42388224-B4A384AA-0A16-4920-86D8-0BB86FCABAE1 Q55261697-8F80669A-F6C3-40E0-915E-79593EF95C1E Q55352555-F6F3F0A8-3EAE-4535-A959-2DC08C2909FC

P2860

Long-term effects of goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial.

http://www.wikidata.org/entity/Q37725008

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term effects of goshajink ...... d open-labeled clinical trial.

@en

Long-term effects of goshajink ...... d open-labeled clinical trial.

@nl

type

label

Long-term effects of goshajink ...... d open-labeled clinical trial.

@en

Long-term effects of goshajink ...... d open-labeled clinical trial.

@nl

prefLabel

Long-term effects of goshajink ...... d open-labeled clinical trial.

@en

Long-term effects of goshajink ...... d open-labeled clinical trial.

@nl

P1433

Q37725008-BC0702CD-D308-4A71-9939-6F73F5C111BD

P1476

Q37725008-C9273A1B-DD2D-4E3D-A9E3-F6C53AC24BAD

P2093

Q37725008-2C4CCB2A-CE61-4FFD-855B-CAF96CCE4382

Q37725008-3F14BED8-241E-432F-982E-0DC42A2E469D

Q37725008-6740D50B-BC70-4083-91B7-090923FCDE7B

Q37725008-9BA34F53-C6C7-4F80-AB16-645CFCDEEDDA

Q37725008-C23B3C7D-E49F-412C-821C-D595C7ECFDAD

Q37725008-E815E9DF-A69A-4997-B501-7374BD4A80E2

Q37725008-EC150DA2-820E-4018-8130-79E8A1A75122

P2860

Q37725008-0F821FDE-8079-4C96-8FED-53C7F11AA3BF

Q37725008-136956D5-3EB2-4680-8AE8-BAD680087C61

Q37725008-16E79DE0-F6AD-42BC-B58A-D75F60323EFF

Q37725008-23B98B03-3E9C-461F-BD30-FE3590997FC9

Q37725008-2AC4F800-FC44-4527-8A23-CB8F146A59D2

Q37725008-3C963CF1-B141-409D-BF14-7D2901C485CD

Q37725008-43BFBD88-0CCB-41C0-8DD4-1E1674B02E2B

Q37725008-54B86706-CC34-409E-ADBC-E97882D1A2EE

Q37725008-5AB5B503-643D-4E80-8DA8-C80A572F11C3

Q37725008-820F133B-3176-4034-AA5B-A5CBEB7F01BD

P304

Q37725008-5FF70D9C-E2FC-4BE4-B822-91D4905D3F45

P31

Q37725008-EFBF6B42-A23E-4744-B4B7-67DE210E4F3D

P356

Q37725008-98D8D79D-8E3C-41DF-B352-51CC01C83710

P478

Q37725008-BEC59220-E189-4A1D-8200-9318A4A5F746

P577

Q37725008-15890BC1-D296-4C24-A0DA-F0DEB2248742

P5875

Q37725008-D9C60E57-3319-4673-BC30-467C8795C365

P698

Q37725008-E8437AF4-19C5-40D6-9267-CF72233AF0A0

P932

Q37725008-AAD24EA4-C1F7-4851-AF5A-3ECBC9FAC9B9

P356

P1433

Evidence-based Complementary and Alternative Medicine

P1476

Long-term effects of goshajink ...... d open-labeled clinical trial.

@en

P2093

A Hirakata

http://www.w3.org/2001/XMLSchema#string

A Shimada

http://www.w3.org/2001/XMLSchema#string

I Takei

http://www.w3.org/2001/XMLSchema#string

K Matsuoka

http://www.w3.org/2001/XMLSchema#string

K Miyaki

http://www.w3.org/2001/XMLSchema#string

K Omae

http://www.w3.org/2001/XMLSchema#string

K Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes.

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

Lifestyle change and mobility in obese adults with type 2 diabetes.

Effect of strict glycemic control in patients with diabetes mellitus on frequency of macrovascular events.

Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats.

Effects of goshajinkigan on corneal sensitivity, superficial punctate keratopathy and tear secretion in patients with insulin-dependent diabetes mellitus.

P304

128726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/128726

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262194181

http://www.w3.org/2001/XMLSchema#string

P698

24812564

http://www.w3.org/2001/XMLSchema#string

P932

4000675

http://www.w3.org/2001/XMLSchema#string